Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-04-02 Purchase |
2025-04-15 12:50 pm |
NovaBay Pharmaceuticals Inc. | NBY | POPLAR POINT CAPITAL PARTNERS LP POPLAR POINT CAPITAL MANAGEMENT LLC POPLAR POINT CAPITAL GP LLC FAKHRY JAD 10% Owner |
28,731 | $0.55574 | $15,967 | 1,020,300 (Direct) |
View |
| 2025-03-26 Purchase |
2025-04-15 12:46 pm |
NovaBay Pharmaceuticals Inc. | NBY | POPLAR POINT CAPITAL PARTNERS LP POPLAR POINT CAPITAL MANAGEMENT LLC POPLAR POINT CAPITAL GP LLC FAKHRY JAD 10% Owner |
123,365 | $0.60405 | $74,519 | 991,569 (Direct) |
View |
| 2025-03-18 Purchase |
2025-04-15 12:40 pm |
NovaBay Pharmaceuticals Inc. | NBY | POPLAR POINT CAPITAL PARTNERS LP POPLAR POINT CAPITAL MANAGEMENT LLC POPLAR POINT CAPITAL GP LLC FAKHRY JAD 10% Owner |
49,927 | $0.61526 | $30,718 | 868,204 (Direct) |
View |
| 2025-03-10 Purchase |
2025-04-15 12:30 pm |
NovaBay Pharmaceuticals Inc. | NBY | POPLAR POINT CAPITAL PARTNERS LP POPLAR POINT CAPITAL MANAGEMENT LLC POPLAR POINT CAPITAL GP LLC FAKHRY JAD 10% Owner |
64,175 | $0.61555 | $39,503 | 818,277 (Direct) |
View |
| 2025-02-25 Purchase |
2025-04-15 12:22 pm |
NovaBay Pharmaceuticals Inc. | NBY | POPLAR POINT CAPITAL PARTNERS LP POPLAR POINT CAPITAL MANAGEMENT LLC POPLAR POINT CAPITAL GP LLC FAKHRY JAD 10% Owner |
48,930 | $0.61021 | $29,858 | 754,102 (Direct) |
View |
| 2025-02-03 Purchase |
2025-04-15 12:18 pm |
NovaBay Pharmaceuticals Inc. | NBY | POPLAR POINT CAPITAL PARTNERS LP POPLAR POINT CAPITAL MANAGEMENT LLC POPLAR POINT CAPITAL GP LLC FAKHRY JAD 10% Owner |
84,487 | $0.65722 | $55,527 | 705,172 (Direct) |
View |
| 2025-01-27 Purchase |
2025-04-15 12:11 pm |
NovaBay Pharmaceuticals Inc. | NBY | POPLAR POINT CAPITAL PARTNERS LP POPLAR POINT CAPITAL MANAGEMENT LLC POPLAR POINT CAPITAL GP LLC FAKHRY JAD 10% Owner |
102,388 | $0.66121 | $67,700 | 620,685 (Direct) |
View |
| 2022-12-06 Sale |
2022-12-07 4:55 pm |
NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer |
1 | $1.81 | $2 | 0 (Indirect) |
View |
| 2022-12-06 Sale |
2022-12-07 4:55 pm |
NovaBay Pharmaceuticals Inc. | NBY | Kunin Jeffrey President, DERMAdoctor, LLC |
1 | $1.81 | $2 | 0 (Indirect) |
View |
| 2022-11-21 Sale(A) |
2022-12-05 5:30 pm |
NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer |
5,960 | $2.1049 | $12,545 | 1 (Indirect) |
View |
| 2022-11-21 Sale(A) |
2022-12-05 5:30 pm |
NovaBay Pharmaceuticals Inc. | NBY | Kunin Jeffrey President, DERMAdoctor, LLC |
5,960 | $2.1049 | $12,545 | 1 (Indirect) |
View |
| 2022-11-21 Sale |
2022-11-23 4:16 pm |
NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer |
5,960 | $2.1049 | $12,545 | 0 (Indirect) |
View |
| 2022-11-21 Sale |
2022-11-23 4:15 pm |
NovaBay Pharmaceuticals Inc. | NBY | Kunin Jeffrey President, DERMAdoctor, LLC |
5,960 | $2.1049 | $12,545 | 0 (Indirect) |
View |
| 2022-09-14 Purchase |
2022-09-16 8:45 pm |
NovaBay Pharmaceuticals Inc. | NBY | Hall Justin CEO, GC and Director |
10,000 | $0.15 | $1,500 | 83,172 (Direct) |
View |
| 2022-09-14 Sale |
2022-09-16 6:26 pm |
NovaBay Pharmaceuticals Inc. | NBY | Kunin Jeffrey President, DERMAdoctor, LLC |
291,368 | $0.1582 | $46,094 | 208,632 (Indirect) |
View |
| 2022-09-14 Sale |
2022-09-16 6:24 pm |
NovaBay Pharmaceuticals Inc. | NBY | Kunin Audrey Chief Product Officer |
291,368 | $0.1582 | $46,094 | 208,632 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
Ownership |
2025-04-07 4:30 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | POPLAR POINT CAPITAL PARTNERS LP POPLAR POINT CAPITAL MANAGEMENT LLC POPLAR POINT CAPITAL GP LLC FAKHRY JAD 10% Owner |
0 | $0 | 518,297 (Direct) |
View |
| 2024-05-28 Option Award |
2024-05-30 9:31 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Garlikov Julie Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-05-28 Option Award |
2024-05-30 9:29 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Freiman Paul E. Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-05-28 Option Award |
2024-05-30 9:27 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Sit Swan Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-05-28 Option Award |
2024-05-30 9:24 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | WU MIJIA Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-05-28 Option Award |
2024-05-30 9:22 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Zheng Yenyou Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-05-28 Option Award |
2024-05-30 9:17 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Zheng Yongxiang Director |
30,000 | $0 | 30,000 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:04 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Freiman Paul E. Director |
858 | $0 | 858 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:04 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Garlikov Julie Director |
858 | $0 | 858 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:03 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Zheng Yenyou Director |
858 | $0 | 858 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:02 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Zheng Yongxiang Director |
858 | $0 | 858 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:02 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Sit Swan Director |
858 | $0 | 858 (Direct) |
View |
| 2023-06-09 Option Award |
2023-06-13 5:01 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | WU MIJIA Director |
858 | $0 | 858 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 6:54 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Freiman Paul E. Director |
858 | $0 | 1,783 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 6:54 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Zheng Yenyou Director |
858 | $0 | 1,716 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 6:53 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | WU MIJIA Director |
858 | $0 | 1,716 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 6:53 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Sit Swan Director |
858 | $0 | 1,716 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 6:53 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Garlikov Julie Director |
858 | $0 | 858 (Direct) |
View |
| 2023-05-11 Exercise |
2023-05-15 6:52 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Zheng Yongxiang Director |
858 | $0 | 858 (Direct) |
View |
Ownership |
2023-02-24 4:45 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Law Tommy Interim CFO |
0 | $0 | 858 (Direct) |
View |
| 2022-05-21 Exercise |
2022-05-24 7:33 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | WU MIJIA Director |
30,000 | $0 | 60,000 (Direct) |
View |
| 2022-05-21 Exercise |
2022-05-24 7:31 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Zheng Yenyou Director |
30,000 | $0 | 60,000 (Direct) |
View |
| 2022-05-21 Exercise |
2022-05-24 7:30 pm |
N/A N/A |
NovaBay Pharmaceuticals Inc. | NBY | Freiman Paul E. Director |
30,000 | $0 | 62,311 (Direct) |
View |